Pfizer Ltd
NSE:PFIZER

Watchlist Manager
Pfizer Ltd Logo
Pfizer Ltd
NSE:PFIZER
Watchlist
Price: 5 293.6499 INR 0.57%
Market Cap: 242.2B INR
Have any thoughts about
Pfizer Ltd?
Write Note

Pfizer Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pfizer Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Pfizer Ltd
NSE:PFIZER
Cost of Revenue
-â‚ą7.8B
CAGR 3-Years
5%
CAGR 5-Years
-1%
CAGR 10-Years
-5%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cost of Revenue
-â‚ą84.5B
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cost of Revenue
-â‚ą87.5B
CAGR 3-Years
-3%
CAGR 5-Years
-9%
CAGR 10-Years
-8%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cost of Revenue
-â‚ą104.9B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-8%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cost of Revenue
-â‚ą27.5B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
-8%
M
Mankind Pharma Ltd
NSE:MANKIND
Cost of Revenue
-â‚ą34B
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pfizer Ltd
Glance View

Market Cap
242.2B INR
Industry
Pharmaceuticals

Pfizer Ltd. engages in the business of manufacturing, marketing, trading, import and export of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 2,285 full-time employees. The firm has a portfolio of approximately 150 products across over 15 therapeutic areas. The firm is engaged in manufacturing, marketing, trading and exporting pharmaceutical products. The firm offers a range of products for anti-diabetic, anti-infectives, cardiovascular, dermatology, erectile dysfunction, gastrointestinal (GI), multivitamins, neurology, pain/fever/inflammation and autoimmune disorders, among others. Its products include Trulimax, Vibazime DT, Viagra, Daxid, Tricorex, Mucaine, Diamox, Hetrazan, Enbrel, Ativan, Pacitane, Folvite Tablets, Autrin Capsules, Prevenar 13, Wysolone, Loette, Ovral G, Ovral L, Premarin tablets, Premarin Vaginal Cream, Zosyn, Wymox, Tygacil, Cynomycin, Targit, Cyklokapron and Magnamycin. The firm has its own manufacturing facility at Thane and Goa. The firm has various independent contract/third party manufacturers based across the country.

PFIZER Intrinsic Value
2 634.7856 INR
Overvaluation 50%
Intrinsic Value
Price

See Also

What is Pfizer Ltd's Cost of Revenue?
Cost of Revenue
-7.8B INR

Based on the financial report for Sep 30, 2024, Pfizer Ltd's Cost of Revenue amounts to -7.8B INR.

What is Pfizer Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-5%

Over the last year, the Cost of Revenue growth was 8%. The average annual Cost of Revenue growth rates for Pfizer Ltd have been 5% over the past three years , -1% over the past five years , and -5% over the past ten years .

Back to Top